Clinical Trial Update: Adjuvant Melatonin for Uveal Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant melatonin for uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Gustav Stalhammar | Conditions: Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size | Phase 3 | Status: RECRUITING